Cargando…
Chemotherapy induces adaptive drug resistance and metastatic potentials via phenotypic CXCR4-expressing cell state transition in ovarian cancer
Ovarian cancer (OVC) patients who receive chemotherapy often acquire drug resistance within one year. This can lead to tumor reoccurrence and metastasis, the major causes of mortality. We report a transient increase of a small distinctive CXCR4(High)/CD24(Low) cancer stem cell population (CXCR4(High...
Autores principales: | Lee, Hyun Hee, Bellat, Vanessa, Law, Benedict |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5308810/ https://www.ncbi.nlm.nih.gov/pubmed/28196146 http://dx.doi.org/10.1371/journal.pone.0171044 |
Ejemplares similares
-
A Urinary Drug-Disposing Approach as an Alternative to Intravesical Chemotherapy for Treating Nonmuscle Invasive Bladder Cancer
por: Bellat, Vanessa, et al.
Publicado: (2022) -
Transcriptomic insight into salinomycin mechanisms in breast cancer cell lines: synergistic effects with dasatinib and induction of estrogen receptor β
por: Bellat, Vanessa, et al.
Publicado: (2020) -
Temporally sequenced anticancer drugs overcome adaptive resistance by targeting a vulnerable chemotherapy-induced phenotypic transition
por: Goldman, Aaron, et al.
Publicado: (2015) -
CXCR4 drives the metastatic phenotype in breast cancer through induction of CXCR2 and activation of MEK and PI3K pathways
por: Sobolik, Tammy, et al.
Publicado: (2014) -
High ratio of pCXCR4/CXCR4 tumor infiltrating immune cells in primary high grade ovarian cancer is indicative for response to chemotherapy
por: Walther, Fabio, et al.
Publicado: (2022)